Anastrozole Tablets
1mg
The product is utilized to alleviate hormonal signals influencing tissue growth in specific patient populations.
PCT and men’s fitness medicines in this category relate to hormone signalling, estrogen control, and reproductive-axis recovery. This is a high-risk category where lab testing and clinical context matter more than gym shorthand.
1mg
The product is utilized to alleviate hormonal signals influencing tissue growth in specific patient populations.
50mg
Utilized to support hormonal balance by targeting oestrogen receptors to alleviate indicators of secondary hypogonadism in men.
1mg
Arimidex is developed to target hormone-dependent breast cancer and is formulated to alleviate tumour progression.
1mg
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
25mg
Developed to target oestrogen production and indicated to support cancer treatment, this inhibitor is utilized to address hormone-sensitive malignancies.
25 · 50 · 100mg
Developed to target ovulation cycles in women experiencing infertility, indicated to support fertility by stimulating hormonal pathways.
50mg
The product is formulated to address hormonal balance in specific endocrine health needs.
25 · 50 · 100mg
developed to support fertility in women and indicated to target the endocrine system for improved ovulatory function.
10 · 20mg
Indicated to support to mitigate breast cancer progression, utilized in patients requiring hormonal manipulation for effective disease management.
Post-cycle therapy discussions often compress complex endocrine feedback into simple formulas. In reality, testosterone, luteinising hormone, follicle-stimulating hormone, estradiol, prolactin, fertility, lipids, liver markers, and mood can all be involved.
Some medicines listed here were developed for fertility, breast cancer, or endocrine indications. Using them for fitness-related hormone manipulation can carry risks and should not be treated as routine supplementation.
SERMs change estrogen signalling at receptors and may affect reproductive hormones. They can have clot, vision, mood, and liver-related concerns depending on patient factors.
Aromatase inhibitors reduce estrogen production. Too much suppression can affect bones, lipids, mood, joints, and sexual function.
Some medicines influence pituitary or testicular signalling. Their effect depends on the underlying endocrine state and should be interpreted with lab results.
Seek medical advice for chest pain, shortness of breath, leg swelling, severe mood change, vision symptoms, jaundice, or testicular pain.
Disclose anabolic steroid use, testosterone therapy, fertility plans, supplements, and previous clotting or cancer history to any clinician involved.
PCT and men’s fitness medicines affect endocrine pathways and can carry serious risks. This page is educational and does not support unsupervised hormone manipulation, self-treatment, or use outside medical guidance.